Antibiotic Duration and Outcomes in High-Risk Febrile Neutropenia Patients — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Antibiotic Duration and Outcomes in High-Risk Febrile Neutropenia Patients — Stella

Home/Bloodstream Infection/

View on ClinicalTrials.gov

Recruiting

Back to Bloodstream Infection trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

Italy

Microbiology and Virology - IRCCS Humanitas Research Hospital, Rozzano, Milan

Key details

Sponsor

Humanitas University

Collaborators

Ministry of education, university and research, Italy

Enrollment target

~172 participants

Started

May 2025

Primary completion

February 2026

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years and older

Last updated January 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.